Prediction of epigenetically regulated genes in breast cancer cell lines
<p>Abstract</p> <p>Background</p> <p>Methylation of CpG islands within the DNA promoter regions is one mechanism that leads to aberrant gene expression in cancer. In particular, the abnormal methylation of CpG islands may silence associated genes. Therefore, using high-...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-06-01
|
Series: | BMC Bioinformatics |
Online Access: | http://www.biomedcentral.com/1471-2105/11/305 |
id |
doaj-74a00bf5e26c4f45ac442555abc20c91 |
---|---|
record_format |
Article |
spelling |
doaj-74a00bf5e26c4f45ac442555abc20c912020-11-24T22:22:23ZengBMCBMC Bioinformatics1471-21052010-06-0111130510.1186/1471-2105-11-305Prediction of epigenetically regulated genes in breast cancer cell linesLu YontaoMoorhead MartinCarlton Victoria EHFlaucher DianeNautiyal ShivaniDurinck SteffenSadanandam AngurajLoss Leandro AGray Joe WFaham MalekSpellman PaulParvin Bahram<p>Abstract</p> <p>Background</p> <p>Methylation of CpG islands within the DNA promoter regions is one mechanism that leads to aberrant gene expression in cancer. In particular, the abnormal methylation of CpG islands may silence associated genes. Therefore, using high-throughput microarrays to measure CpG island methylation will lead to better understanding of tumor pathobiology and progression, while revealing potentially new biomarkers. We have examined a recently developed high-throughput technology for measuring genome-wide methylation patterns called mTACL. Here, we propose a computational pipeline for integrating gene expression and CpG island methylation profles to identify epigenetically regulated genes for a panel of 45 breast cancer cell lines, which is widely used in the Integrative Cancer Biology Program (ICBP). The pipeline (i) reduces the dimensionality of the methylation data, (ii) associates the reduced methylation data with gene expression data, and (iii) ranks methylation-expression associations according to their epigenetic regulation. Dimensionality reduction is performed in two steps: (i) methylation sites are grouped across the genome to identify regions of interest, and (ii) methylation profles are clustered within each region. Associations between the clustered methylation and the gene expression data sets generate candidate matches within a fxed neighborhood around each gene. Finally, the methylation-expression associations are ranked through a logistic regression, and their significance is quantified through permutation analysis.</p> <p>Results</p> <p>Our two-step dimensionality reduction compressed 90% of the original data, reducing 137,688 methylation sites to 14,505 clusters. Methylation-expression associations produced 18,312 correspondences, which were used to further analyze epigenetic regulation. Logistic regression was used to identify 58 genes from these correspondences that showed a statistically signifcant negative correlation between methylation profles and gene expression in the panel of breast cancer cell lines. Subnetwork enrichment of these genes has identifed 35 common regulators with 6 or more predicted markers. In addition to identifying epigenetically regulated genes, we show evidence of differentially expressed methylation patterns between the basal and luminal subtypes.</p> <p>Conclusions</p> <p>Our results indicate that the proposed computational protocol is a viable platform for identifying epigenetically regulated genes. Our protocol has generated a list of predictors including COL1A2, TOP2A, TFF1, and VAV3, genes whose key roles in epigenetic regulation is documented in the literature. Subnetwork enrichment of these predicted markers further suggests that epigenetic regulation of individual genes occurs in a coordinated fashion and through common regulators.</p> http://www.biomedcentral.com/1471-2105/11/305 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Lu Yontao Moorhead Martin Carlton Victoria EH Flaucher Diane Nautiyal Shivani Durinck Steffen Sadanandam Anguraj Loss Leandro A Gray Joe W Faham Malek Spellman Paul Parvin Bahram |
spellingShingle |
Lu Yontao Moorhead Martin Carlton Victoria EH Flaucher Diane Nautiyal Shivani Durinck Steffen Sadanandam Anguraj Loss Leandro A Gray Joe W Faham Malek Spellman Paul Parvin Bahram Prediction of epigenetically regulated genes in breast cancer cell lines BMC Bioinformatics |
author_facet |
Lu Yontao Moorhead Martin Carlton Victoria EH Flaucher Diane Nautiyal Shivani Durinck Steffen Sadanandam Anguraj Loss Leandro A Gray Joe W Faham Malek Spellman Paul Parvin Bahram |
author_sort |
Lu Yontao |
title |
Prediction of epigenetically regulated genes in breast cancer cell lines |
title_short |
Prediction of epigenetically regulated genes in breast cancer cell lines |
title_full |
Prediction of epigenetically regulated genes in breast cancer cell lines |
title_fullStr |
Prediction of epigenetically regulated genes in breast cancer cell lines |
title_full_unstemmed |
Prediction of epigenetically regulated genes in breast cancer cell lines |
title_sort |
prediction of epigenetically regulated genes in breast cancer cell lines |
publisher |
BMC |
series |
BMC Bioinformatics |
issn |
1471-2105 |
publishDate |
2010-06-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Methylation of CpG islands within the DNA promoter regions is one mechanism that leads to aberrant gene expression in cancer. In particular, the abnormal methylation of CpG islands may silence associated genes. Therefore, using high-throughput microarrays to measure CpG island methylation will lead to better understanding of tumor pathobiology and progression, while revealing potentially new biomarkers. We have examined a recently developed high-throughput technology for measuring genome-wide methylation patterns called mTACL. Here, we propose a computational pipeline for integrating gene expression and CpG island methylation profles to identify epigenetically regulated genes for a panel of 45 breast cancer cell lines, which is widely used in the Integrative Cancer Biology Program (ICBP). The pipeline (i) reduces the dimensionality of the methylation data, (ii) associates the reduced methylation data with gene expression data, and (iii) ranks methylation-expression associations according to their epigenetic regulation. Dimensionality reduction is performed in two steps: (i) methylation sites are grouped across the genome to identify regions of interest, and (ii) methylation profles are clustered within each region. Associations between the clustered methylation and the gene expression data sets generate candidate matches within a fxed neighborhood around each gene. Finally, the methylation-expression associations are ranked through a logistic regression, and their significance is quantified through permutation analysis.</p> <p>Results</p> <p>Our two-step dimensionality reduction compressed 90% of the original data, reducing 137,688 methylation sites to 14,505 clusters. Methylation-expression associations produced 18,312 correspondences, which were used to further analyze epigenetic regulation. Logistic regression was used to identify 58 genes from these correspondences that showed a statistically signifcant negative correlation between methylation profles and gene expression in the panel of breast cancer cell lines. Subnetwork enrichment of these genes has identifed 35 common regulators with 6 or more predicted markers. In addition to identifying epigenetically regulated genes, we show evidence of differentially expressed methylation patterns between the basal and luminal subtypes.</p> <p>Conclusions</p> <p>Our results indicate that the proposed computational protocol is a viable platform for identifying epigenetically regulated genes. Our protocol has generated a list of predictors including COL1A2, TOP2A, TFF1, and VAV3, genes whose key roles in epigenetic regulation is documented in the literature. Subnetwork enrichment of these predicted markers further suggests that epigenetic regulation of individual genes occurs in a coordinated fashion and through common regulators.</p> |
url |
http://www.biomedcentral.com/1471-2105/11/305 |
work_keys_str_mv |
AT luyontao predictionofepigeneticallyregulatedgenesinbreastcancercelllines AT moorheadmartin predictionofepigeneticallyregulatedgenesinbreastcancercelllines AT carltonvictoriaeh predictionofepigeneticallyregulatedgenesinbreastcancercelllines AT flaucherdiane predictionofepigeneticallyregulatedgenesinbreastcancercelllines AT nautiyalshivani predictionofepigeneticallyregulatedgenesinbreastcancercelllines AT durincksteffen predictionofepigeneticallyregulatedgenesinbreastcancercelllines AT sadanandamanguraj predictionofepigeneticallyregulatedgenesinbreastcancercelllines AT lossleandroa predictionofepigeneticallyregulatedgenesinbreastcancercelllines AT grayjoew predictionofepigeneticallyregulatedgenesinbreastcancercelllines AT fahammalek predictionofepigeneticallyregulatedgenesinbreastcancercelllines AT spellmanpaul predictionofepigeneticallyregulatedgenesinbreastcancercelllines AT parvinbahram predictionofepigeneticallyregulatedgenesinbreastcancercelllines |
_version_ |
1725768604344909824 |